340B HEALTH for 340B HEALTH
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The 340B Drug Pricing program, Health Resources and Services Administration 340B Drug Pricing Program Omnibus Guidance, FY17 Labor Health and Human Services Appropriations, Delaware Medicaid State Plan Amendment, CMS Medicaid and CHIP Managed Care Final Rule, CMS Covered Outpatient Drug Final Regulation,340B Ceiling Price and Manufacturer Civil Monetary Penalties Regulation, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates,Part B Drug Payment Model Proposed Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY IRVING DAVIS | — |
| KATHRYN DIBITETTO | — |
| GREG DOGGETT | — |
| TED SLAFSKY | — |
| AMANDA SELLERS SMITH New | — |
| LIAM STEADMAN | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.